Fiche centre
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence — Italy
Essais liés4clinical trials
VilleFlorencelocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05903040
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Atogepant 60 mg | Migraine | À vérifier | NCT06414044 | STAR — Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients | ACTIVE_NOT_RECRUITING |
| Rimegepant 75 MG Disintegrating Oral Tablet | Migraine | À vérifier | NCT05903027 | Gepant treAtments: EffectIveNess and tolERability (GAINER) | RECRUITING |
| Rimegepant 75 MG | Migraine | À vérifier | NCT06409832 | RAISE — RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | RECRUITING |
| Lasmiditan | Migraine | À vérifier | NCT05903040 | Ditan Acute tReatments: Effectiveness and Tolerability (DART) | COMPLETED |